Junshi Biosciences and Coherus plan to evaluate the toripalimab + JS006 combination in clinical trials in multiple tumor types Combinations of PD-1 + TIGIT inhibitors
Successful performance of plasma compression prototype confirms path to commercialization General Fusion’s plasma compression prototype VANCOUVER, British Columbia, Jan. 10, 2022 (GLOBE NEWSWIRE) — General
BEIJING and LONDON and PARIS and SAN FRANCISCO, Jan. 10, 2022 (GLOBE NEWSWIRE) — After overwhelming demand, creative offers and global inquires from it’s recent
CHIPPENHAM, United Kingdom, Jan. 10, 2022 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq: DSGX) (TSX: DSG), the global leader in uniting logistics-intensive businesses in commerce,
Published by Al-Araby China is willing to increase “law enforcement and security” cooperation with neighbouring Kazakhstan and help oppose interference by “external forces”, China’s foreign
Khondrion completes enrolment in KHENERGYZE Phase IIb trial evaluating sonlicromanol in adult patients with MELAS spectrum disorders NIJMEGEN, the Netherlands – 10 January 2022: Khondrion,
MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed BV® test recently cleared for use by US FDA to aid in
Nyxoah Provides General Corporate Update Transformational 2021 positions Nyxoah for further clinical, regulatory, and commercial milestones in 2022 Mont-Saint-Guibert, Belgium – January 10, 2022, 7:00am
Taiwan on Monday confirmed six new domestic COVID-19 cases, all linked to Taoyuan International Airport, and 26 new imported cases, according to the Central Epidemic
Taiwan shares closed up 69.62 points, or 0.38 percent, at 18,239.38 Monday on turnover of NT$270.99 billion (US$9.78 billion).Source: Focus Taiwan News Channel